Literature DB >> 34878559

[What is confirmed in the diagnostics of autoinflammatory fever diseases?]

Stephen Gilbert1,2,3, Heinz Gabriel4, Anne Pankow5,6, Saskia Biskup4, Annette Doris Wagner7.   

Abstract

Periodic fever syndromes (PFS) are a group of rare autoinflammatory diseases, which are characterized by disorders of the innate immune reaction and life-long recurrent episodes of inflammatory symptoms. This article describes the diagnostic approach. In addition to the patient medical history, physical examination and laboratory determinations, gene tests are becoming increasingly more important. The panel diagnostics using high throughput sequencing or next generation sequencing (NGS) is the method of choice for the detection of a genetic cause of PFS. This article discusses the diagnostic decision support systems (DDSS) that can play a future role in the diagnosis of rare diseases, especially those with complex patterns of symptoms.
© 2021. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Clinical decision support systems; Hereditary periodic fever syndromes; High-throughput nucleotide sequencing; Next-generation sequencing; Whole exome sequencing

Mesh:

Year:  2021        PMID: 34878559     DOI: 10.1007/s00108-021-01221-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  2 in total

1.  Clinical features and new diagnostic criteria for the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis.

Authors:  Yusuke Takeuchi; Tomonari Shigemura; Norimoto Kobayashi; Haruo Nagumo; Masahiro Furumoto; Kyo Ogasawara; Hitomi Fujii; Masahiro Takizawa; Takashi Soga; Hisanori Matoba; Junya Masumoto; Keitaro Fukushima; Kiyoshi Migita; Toshiyuki Ojima; Yoh Umeda; Kazunaga Agematsu
Journal:  Int J Rheum Dis       Date:  2019-05-27       Impact factor: 2.454

Review 2.  A clinical review of 105 patients with PFAPA (a periodic fever syndrome).

Authors:  H M Feder; J C Salazar
Journal:  Acta Paediatr       Date:  2009-11-04       Impact factor: 2.299

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.